Share

June 02, 2015; 84 (22) Article

Healthy eating and reduced risk of cognitive decline

A cohort from 40 countries

Andrew Smyth, Mahshid Dehghan, Martin O'Donnell, Craig Anderson, Koon Teo, Peggy Gao, Peter Sleight, Gilles Dagenais, Jeffrey L. Probstfield, Andrew Mente, Salim Yusuf
First published May 6, 2015, DOI: https://doi.org/10.1212/WNL.0000000000001638
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
975

Share

Article Information

vol. 84 no. 22 2258-2265
DOI: 
https://doi.org/10.1212/WNL.0000000000001638
PubMed: 
25948720
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received October 2, 2014
  • Accepted in final form February 19, 2015
  • First Published May 6, 2015.

Article Versions

Copyright & Usage: 
© 2015 American Academy of Neurology

Author Disclosures

    1. Andrew Smyth, MMedSc*,
    2. Mahshid Dehghan, PhD*,
    3. Martin O'Donnell, PhD,
    4. Craig Anderson, MD,
    5. Koon Teo, MD,
    6. Peggy Gao, MSc,
    7. Peter Sleight, DM,
    8. Gilles Dagenais, MD,
    9. Jeffrey L. Probstfield, MD,
    10. Andrew Mente, PhD and
    11. Salim Yusuf, DPhil
    12. On behalf of the ONTARGET and TRANSCEND Investigators
  1. Andrew Smyth, MMedSc*,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Health Services Executive and Health Research Board of Ireland, NSAFP/2011/2, Research Fellowship Support, 2011-2015

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Mahshid Dehghan, PhD*,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Martin O'Donnell, PhD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Bayer, BI, BMS, Pfizer for presentations

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Craig Anderson, MD,
    5. Scientific Advisory Boards:

    1. Pfizer Inc and The Medicines Company

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Receives honoraria from serving on the scientific advisory board for Pfizer Inc and The Medicines Company; receives funding for travel from Takeda China and Covidien

    Editorial Boards:

    1. Stroke, Cerebrovascular Diseases, Medical Journal of Australia

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Program grant (1052555), Project grant (1020462) and Fellowship (1081356) support from the National Health and Medical Research Council (NHMRC) of Australia.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Koon Teo, MD,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Peggy Gao, MSc,
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Peter Sleight, DM,
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Boehringer Ingelheim, honoraria and expenses during the conduct of ONTARGET/TRANSCEND

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  8. Gilles Dagenais, MD,
    9. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  9. Jeffrey L. Probstfield, MD,
    10. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Non profit. Consultancy with Population Health Research Institute, McMaster University, Hamilton, Ontario

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Sanofi Pharmaceuticals-Research Grant Bristol Myers Squibb-Research Grant Astra Zeneca-Research Grant

    Research Support, Government Entities:

    1. NHLBI-ACCORDION Follow-up

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  10. Andrew Mente, PhD and
    11. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  11. Salim Yusuf, DPhil
    12. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Boehringer Ingelheim, Bayer, Travel and Honorarium.

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Boehringer Ingelheim, Bayer, Astra Zeneca, Cadila Pharma, Sanofi Aventis

    Research Support, Government Entities:

    1. CIHR (Several grants as PI/OPI).

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Wellcome Trust, UK Heart and Stroke Foundation of Canada

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

    1. From the Population Health Research Institute (A.S., M.D., M.O.D., K.T., P.G., A.M., S.Y.), McMaster University, Hamilton, Canada; Health Research Board Clinical Research Facility (A.S., M.O.D.), National University of Ireland, Galway; The George Institute for Global Health (C.A.), Australia; Nuffield Department of Medicine (P.S.), John Radcliffe Hospital, Oxford, UK; Laval University Heart and Lung Institute (G.D.), Quebec, Canada; and University of Washington (J.L.P.), School of Medicine, Seattle, WA.
    1. Correspondence to Andrew Smyth: andrew.smyth{at}phri.ca

    Article usage

    Article usage: May 2015 to October 2023

    AbstractFullPdfSource
    May 201560424124Highwire
    Jun 2015290348113Highwire
    Jul 201512741937Highwire
    Aug 20157511223Highwire
    Sep 20156681321Highwire
    Oct 2015455238Highwire
    Nov 201551767Highwire
    Dec 201578217Highwire
    Dec 201505728pmc
    Jan 201642646Highwire
    Jan 201606032pmc
    Feb 201631413Highwire
    Feb 201603421pmc
    Mar 201664812Highwire
    Mar 201603719pmc
    Apr 201648600Highwire
    Apr 201604011pmc
    May 201646611Highwire
    May 201601912pmc
    Jun 201647223Highwire
    Jun 201601610pmc
    Jul 201644900Highwire
    Jul 20160209pmc
    Aug 201672401Highwire
    Aug 20160217pmc
    Sep 201643413Highwire
    Sep 201601910pmc
    Oct 201652223Highwire
    Oct 201602715pmc
    Nov 201653812Highwire
    Nov 20160228pmc
    Dec 201630201Highwire
    Dec 20160284pmc
    Jan 201732200Highwire
    Jan 20170252pmc
    Feb 201736502Highwire
    Feb 201703112pmc
    Mar 201732601Highwire
    Mar 20170172pmc
    Apr 201718801Highwire
    Apr 201783243pmc
    May 201718500Highwire
    May 201761922pmc
    Jun 201716200Highwire
    Jun 201741010pmc
    Jul 201722723Highwire
    Jul 2017112125pmc
    Aug 201725801Highwire
    Aug 201784561pmc
    Sep 201714921Highwire
    Sep 2017122929pmc
    Oct 2017230183Highwire
    Oct 201782730pmc
    Nov 201729500Highwire
    Nov 2017182731pmc
    Dec 201713511Highwire
    Jan 201815322Highwire
    Feb 2018120330Highwire
    Mar 201820441Highwire
    Apr 201820220Highwire
    Apr 201883337pmc
    May 201819321Highwire
    Jun 201823500Highwire
    Jun 201841622pmc
    Jul 201818112Highwire
    Aug 201832714Highwire
    Aug 201891626pmc
    Sep 201816103Highwire
    Oct 201818810Highwire
    Nov 201828611Highwire
    Dec 201820810Highwire
    Jan 201916911Highwire
    Feb 201914711Highwire
    Mar 201918210Highwire
    Apr 201918162Highwire
    May 201919900Highwire
    Jun 201910900Highwire
    Jul 201917830Highwire
    Aug 201915450Highwire
    Sep 201915322Highwire
    Oct 201918551Highwire
    Nov 201919211Highwire
    Dec 201917100Highwire
    Jan 202017901Highwire
    Feb 202027632Highwire
    Mar 202017721Highwire
    Apr 202013211Highwire
    May 202018000Highwire
    Jun 202018100Highwire
    Jul 202015142Highwire
    Aug 202022500Highwire
    Sep 202014801Highwire
    Oct 202024910Highwire
    Nov 202020220Highwire
    Dec 202023410Highwire
    Jan 202122801Highwire
    Feb 202117841Highwire
    Mar 202118000Highwire
    Apr 202118520Highwire
    May 202120700Highwire
    Jun 202116702Highwire
    Jul 202125410Highwire
    Aug 202132301Highwire
    Sep 202117000Highwire
    Oct 202123600Highwire
    Nov 202124111Highwire
    Dec 202119820Highwire
    Jan 202219222Highwire
    Feb 202218401Highwire
    Mar 202218300Highwire
    Apr 202217310Highwire
    May 20229801Highwire
    Jun 202210311Highwire
    Jul 202213721Highwire
    Aug 202215321Highwire
    Sep 202222033Highwire
    Oct 202228652Highwire
    Nov 202219332Highwire
    Dec 202213712Highwire
    Jan 202318721Highwire
    Feb 202311601Highwire
    Mar 20238300Highwire
    Apr 202312401Highwire
    May 20239500Highwire
    Jun 202332443Highwire
    Jul 202314210Highwire
    Aug 202310021Highwire
    Sep 20239210Highwire
    Oct 202315700Highwire

    Letters: Rapid online correspondence

    Comment

    REQUIREMENTS

    You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

    Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

    If you are responding to a comment that was written about an article you originally authored:
    You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
    and apply to letter.

    Submission specifications:

    • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
    • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
    • Submit only on articles published within 6 months of issue date.
    • Do not be redundant. Read any comments already posted on the article prior to submission.
    • Submitted comments are subject to editing and editor review prior to posting.

    More guidelines and information on Disputes & Debates

    Compose Comment

    More information about text formats

    Plain text

    • No HTML tags allowed.
    • Web page addresses and e-mail addresses turn into links automatically.
    • Lines and paragraphs break automatically.
    Author Information
    NOTE: The first author must also be the corresponding author of the comment.
    First or given name, e.g. 'Peter'.
    Your last, or family, name, e.g. 'MacMoody'.
    Your email address, e.g. [email protected]
    Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
    Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
    Publishing Agreement
    NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

    Vertical Tabs

    You May Also be Interested in

    Back to top
    Advertisement

    Topics Discussed

    Alert Me

    Recommended articles